Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

January 22, 2024

Study Completion Date

January 22, 2024

Conditions
Follicular Lymphoma
Trial Locations (9)

13273

Institut Paoli Calmettes, Marseille

30029

CHU de Nîmes - Hôpital Carémeau, Nîmes

34295

CHU Saint Eloi; Service d'Hématologie Clinique, Montpellier

35033

CHU Pontchaillou, Rennes

44000

CHU NANTES - Hôtel Dieu; Service d'Hematologie Clinique, Nantes

59037

Hopital Claude Huriez; Hematologie, Lille

64109

Centre Hospitalier de La Cote Basque; Hematologie, Bayonne

75012

Hopital Saint Antoine; Hematologie Clinique, Paris

86021

Hopital De La Miletrie; Hematologie Et Oncologie Medicale, Poitiers

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

The Lymphoma Academic Research Organisation

OTHER